Laos Pharmaceuticals & Healthcare Q4 2018
Laos’s pharmaceutical spending will continue to post high growth rates over the next ten years, albeit from a low base. Infact, despite the government’s commitment towards improving the population’s access to healthcare, the still underdevelopedhealth system will limit drugmaker opportunities. While the rising burden of communicable diseases and the gradual rolling-out ofuniversal healthcare will present improved commercial opportunities for drugmakers over the next decade, the market will remainhighly challenging due to a poor operating environment and the entrenched use of traditional treatments.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook